Literature DB >> 10410969

A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology.

M M Roden1, K H Lee, M C Panelli, F M Marincola.   

Abstract

A novel cellular cytotoxicity assay using Calcein acetoxymethyl (Calcein-AM), a cytoplasmic fluorescent label, has been developed as an alternative to the standard 51Chromium (Cr)-release. Target cells were loaded with Calcein-AM and then co-incubated with effector cells. An additional reagent, FluoroQuench, is added to extinguish fluorescence of dying target cells and of the culture media. Assay plates are read on a quantitative fluorescent scanner for determination of viable target cells. Percent lysis is calculated as one minus the percent viable cells as compared to fluorescent-labeled targets-only wells. The assay was tested to demonstrate the lytic activity of cytotoxic T lymphocyte (CTL) cultures, lymphokine-activated killer (LAK), and natural killer (NK) cell line effectors against peptide-pulsed and melanoma targets. In addition to the acquisition of results comparable to the 51Cr-release assay, the Calcein assay reliably measures cell-mediated cytotoxicity with little variance among replicates. The fluorescent assay represents a simple and useful alternative to the use of radioactive materials and adds the additional benefit of digital images and analysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10410969     DOI: 10.1016/s0022-1759(99)00039-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  26 in total

1.  Evaluation of natural killer cell activity.

Authors:  J H Cox; M deSouza
Journal:  Mol Biotechnol       Date:  2000-06       Impact factor: 2.695

2.  Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay.

Authors:  Bhavin S Parekh; Elaine Berger; Sharon Sibley; Suntara Cahya; Liqun Xiao; Melinda Ann LaCerte; Peter Vaillancourt; Scott Wooden; Dennis Gately
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

3.  Standard fluorescent imaging of live cells is highly genotoxic.

Authors:  Jing Ge; David K Wood; David M Weingeist; Somsak Prasongtanakij; Panida Navasumrit; Mathuros Ruchirawat; Bevin P Engelward
Journal:  Cytometry A       Date:  2013-05-06       Impact factor: 4.355

4.  Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants.

Authors:  S Neri; E Mariani; A Meneghetti; L Cattini; A Facchini
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

5.  Single Degranulations in NK Cells Can Mediate Target Cell Killing.

Authors:  Lavesh A Gwalani; Jordan S Orange
Journal:  J Immunol       Date:  2018-03-28       Impact factor: 5.422

6.  Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders.

Authors:  Jooeun Bae; Yu-Tzu Tai; Kenneth C Anderson; Nikhil C Munshi
Journal:  Br J Haematol       Date:  2011-09-09       Impact factor: 6.998

7.  Conversion of adult endothelium to immunocompetent haematopoietic stem cells.

Authors:  Raphael Lis; Charles C Karrasch; Michael G Poulos; Balvir Kunar; David Redmond; Jose G Barcia Duran; Chaitanya R Badwe; William Schachterle; Michael Ginsberg; Jenny Xiang; Arash Rafii Tabrizi; Koji Shido; Zev Rosenwaks; Olivier Elemento; Nancy A Speck; Jason M Butler; Joseph M Scandura; Shahin Rafii
Journal:  Nature       Date:  2017-05-17       Impact factor: 49.962

8.  Human macrophages kill human mesangial cells by Fas-L-induced apoptosis when triggered by antibody via CD16.

Authors:  J J Boyle
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

9.  Single-dose, therapeutic vaccination of mice with vesicular stomatitis virus expressing human papillomavirus type 16 E7 protein.

Authors:  John B Liao; Jean Publicover; John K Rose; Daniel DiMaio
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

10.  scFv-based "Grababody" as a general strategy to improve recruitment of immune effector cells to antibody-targeted tumors.

Authors:  Zheng Cai; Ting Fu; Yasuhiro Nagai; Lian Lam; Marla Yee; Zhiqiang Zhu; Hongtao Zhang
Journal:  Cancer Res       Date:  2013-02-08       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.